edoc-Server des Robert Koch-Instituts

Dissertation

Autor(en): Marwan Semaan
Titel: Xenotransplantation: Reduction of the risk of transmission of porcine endogenous retroviruses (PERV)
Gutachter: Rupert Mutzel
Betreuer: Joachim Denner
Hochschule: Freie Universität Berlin
Erscheinungsdatum: 01.04.2014
Volltext: pdf (urn:nbn:de:0257-10041736)
Fachgebiet(e): Medizin
Schlagwörter (ger): Xenotransplantation, PERV, RNAi, prevalence, zinc finger nuclease, neutralizing antibodies
Metadatenexport: Um den gesamten Metadatensatz im Endnote- oder Bibtex-Format zu speichern, klicken Sie bitte auf den entsprechenden Link. Endnote   Bibtex  

Abstract (eng):
Xenotransplantation using porcine cells, tissues or organs may reduce the widening gap between demand and supply of human donor organs. However, this may be hampered by the presence of porcine endogenous retroviruses (PERVs), which belong to the γ-retroviruses family and are integrated in the porcine genome and were shown to infect human cells in vitro. Three subtypes of PERVs were identified, PERV-A and PERV-B are human tropic and pose a direct risk and are ubiquitous while PERV-C infect only pig cells and is not present in all pig strains. To date, there are no records of in vivo transmission of PERVs to human or primates following porcine material xenotransplantation. Nevertheless, many of the γ-retroviruses are pathogenic and able to induce tumors and immunodeficiency, which can’t be excluded for PERVs. While breeding animals under SPF conditions may eliminate most of pathogens and exogenous viruses, PERVs are difficult to eradicate from the porcine genome and different strategies must be used to prevent their possible transspecies transmission to human.
The present study is a contribution to the evaluation of the risks imposed by xenotransplantation as well as to the prevention of PERV transmission to human.
Although PERV-C is not human-tropic, the high infectious PERV-A/C which results from the recombination between PERV-A and PERV-C raised a major concern for xenotransplantation. For this reason choosing PERV-C-free strains with low PERV expression is relevant. The first part of this work addresses the prevalence and the expression of PERV in Göttingen minipigs, which are used for numerous biomedical investigations and are well characterized. PERV-A, -B and -C were found in all animals tested and their expression was low. Infection of human 293 cells was not observed even after mitogen treatment of the pig peripheral blood mononuclear cells (PBMCs).
RNA interference was used in order to reduce the expression of PERVs in pigs and transgenic pigs expressing PERV-pol-specific shRNA were generated in our group. In the second part of this study the long term effects of PERV specific RNA interference and reduction of PERV expression in these pigs was investigated. Over 3 years, the expression of shRNA was persistent and PERV expression was consistently reduced in the pig PBMCs. We also investigated the expression of PERV and shRNA in different organs of the pigs. Moreover, new triple-shRNA expressing vectors were produced using high efficient siRNAs. The use of these vectors showed a significant improvement in reducing the PERV expression in vitro.
The third part focuses on the use of zinc finger nucleases (ZFN) to knockout PERV genes. ZFN specific for the PERV-pol gene were used, and expression of ZFN proteins in porcine kidney cells was demonstrated by different methods. However, the high rate of ZFN expression and the high copy number of PERV proviruses seemed to have cytotoxic effects. ZFN activity couldn’t be detected since a surveyor nuclease assay widely used for detection of ZFN induced gene disruption couldn’t be applied in this case.
In the last part vaccine strategies to prevent PERV transmission were investigated. Neutralizing antibodies directed against the recombinant viral envelope proteins gp70 and p15E were produced in hamsters. The neutralization effect of the immunized sera was measured using a qRT-PCR based neutralization assay.
To summarize, this work contributed into improving the reduction of PERV expression by RNAi, and addressed for the first time the possibility of the use of ZFNs to knock out a gene with high copy number such as PERV.
Nutzungsbedingungen
Für Dokumente, die in elektronischer Form auf diesem Dokumentenserver bereitgestellt werden, gilt uneingeschränkt das Urheberrechtsgesetz (UrhG). Vor allem gilt, dass die Dokumente zu wissenschaftlichen Zwecken und zum Eigengebrauch zitiert, kopiert, abgespeichert, ausgedruckt und weitergegeben werden dürfen (§53 UhrG), es sei denn, dem einzelnen Dokument sind abweichende und dann allein maßgebliche Nutzungsbedingungen vorangestellt. Jede kommerzielle Nutzung der Dokumente, auch von Teilen und Auszügen, ist ohne vorherige Zustimmung des Urhebers/Autors untersagt.
Terms of use
Documents which are provided on this repository are subject to strict copyright conditions. This applies in particular to the following: the documents made available on this publication server may be cited, copied, saved, printed and passed on for scientific purposes and private use (§53 German Copyright Law), unless the individual document is preceded by deviating and then exclusively applicable terms and conditions of use. Any commercial use of the documents, even in part and excerpts, is prohibited without the prior written consent of the creator.
Zugriffsstatistik: Die Daten für die Zugriffsstatistik der einzelnen Dokumente wurden aus den durch AWSTATS aggregierten Webserver-Logs erstellt. Sie beziehen sich auf den monatlichen Zugriff auf den Volltext sowie auf die Startseite.
 
Bei Formatversionen eines Dokuments, die aus mehreren Dateien bestehen (insbesondere HTML), wird jeweils der monatlich höchste Zugriffswert auf eine der Dateien (Kapitel) des Dokuments angezeigt.
 
Um die detaillierten Zugriffszahlen zu sehen, fahren Sie bitte mit dem Mauszeiger über die einzelnen Balken des Diagramms.
Startseite: 2 ZugriffePDF: 5 ZugriffeStartseite: 4 ZugriffePDF: 12 ZugriffeStartseite: 11 ZugriffePDF: 9 ZugriffeStartseite: 7 ZugriffePDF: 12 ZugriffeStartseite: 9 ZugriffePDF: 20 ZugriffeStartseite: 6 ZugriffePDF: 13 ZugriffeStartseite: 10 ZugriffePDF: 8 ZugriffeStartseite: 14 ZugriffePDF: 9 ZugriffeStartseite: 6 ZugriffePDF: 9 ZugriffeStartseite: 8 ZugriffePDF: 13 ZugriffeStartseite: 49 ZugriffePDF: 13 ZugriffeStartseite: 76 ZugriffePDF: 17 ZugriffeStartseite: 5 ZugriffePDF: 8 ZugriffeStartseite: 7 ZugriffePDF: 12 Zugriffe
Nov
15
Dec
15
Mar
16
Apr
16
May
16
Jun
16
Jul
16
Aug
16
Sep
16
Oct
16
Nov
16
Dec
16
Jan
17
Feb
17

Gesamtzahl der Zugriffe seit Nov/2015:

  • Startseite – 214 (15.29 pro Monat)
  • PDF – 160 (11.43 pro Monat)
  •  
Generiert am 23.03.2017, 09:13:18